# A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B

> **NCT03714152** · PHASE1 · COMPLETED · sponsor: **Assembly Biosciences** · enrollment: 80 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** ABI-H2158
- **DRUG:** Placebo for ABI-H2158

## Key facts

- **NCT ID:** NCT03714152
- **Lead sponsor:** Assembly Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-13
- **Primary completion:** 2020-11-23
- **Final completion:** 2021-01-07
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03714152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03714152, "A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03714152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*